Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Receivables (2016 - 2025)

Historic Receivables for Xtant Medical Holdings (XTNT) over the last 17 years, with Q3 2025 value amounting to $25.5 million.

  • Xtant Medical Holdings' Receivables rose 2420.05% to $25.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.5 million, marking a year-over-year increase of 2420.05%. This contributed to the annual value of $20.7 million for FY2024, which is 34.25% down from last year.
  • As of Q3 2025, Xtant Medical Holdings' Receivables stood at $25.5 million, which was up 2420.05% from $27.0 million recorded in Q2 2025.
  • Xtant Medical Holdings' Receivables' 5-year high stood at $27.0 million during Q2 2025, with a 5-year trough of $6.3 million in Q3 2021.
  • In the last 5 years, Xtant Medical Holdings' Receivables had a median value of $13.7 million in 2023 and averaged $15.2 million.
  • As far as peak fluctuations go, Xtant Medical Holdings' Receivables crashed by 2787.64% in 2021, and later surged by 9463.36% in 2023.
  • Xtant Medical Holdings' Receivables (Quarter) stood at $7.2 million in 2021, then skyrocketed by 51.71% to $10.9 million in 2022, then surged by 91.02% to $20.7 million in 2023, then dropped by 0.34% to $20.7 million in 2024, then increased by 23.51% to $25.5 million in 2025.
  • Its last three reported values are $25.5 million in Q3 2025, $27.0 million for Q2 2025, and $23.5 million during Q1 2025.